Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease
Clinical trial NCT01624376 · COMPLETED
Trial details
- NCT number
- NCT01624376
- Sponsor
- Delenex Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-02-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.